<DOC>
	<DOC>NCT01055444</DOC>
	<brief_summary>The purpose of the study is to explore the potential usefulness of a heated lidocaine 70 mg/tetracaine 70 mg topical patch for the treatment of pain associated with shoulder impingement syndrome</brief_summary>
	<brief_title>Study Evaluating Heated Lidocaine/Tetracaine Topical Patch in Treatment of Patients With Shoulder Impingement Syndrome</brief_title>
	<detailed_description>The purpose of this single center, 2-week open-label pilot study is to explore the potential usefulness of a heated lidocaine 70 mg and tetracaine 70 mg topical patch for the treatment of pain associated with shoulder impingement syndrome. A number of efficacy variables will be employed to evaluate their utility for assessing painful responses in this population.</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Shoulder Impingement Syndrome</mesh_term>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>Pain associated with shoulder impingement syndrome in a single shoulder Have tenderness at the attachment site of the rotator cuff tendons in the affected shoulder Have positive Hawkins and Neers signs Have used any topically applied pain medication on the target treatment area within 3 days preceding the Screening/Baseline visit Have used any injected pain medication within 14 days preceding the Screening/Baseline visit Are receiving class 1 antiarrhythmic drugs (ie, tocainide, mexiletine, etc.) Have a history of and/or past diagnosis of severe hepatic disease Other protocoldefined inclusion/exclusion criteria may apply</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>